Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study
Süleyman Ersoy, Velittin Selçuk Engin
Clinical Interventions in Aging (2018) Vol. Volume 13, pp. 2003-2011
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

An overview of prevalence, determinants and health outcomes of polypharmacy
Mina Khezrian, Christopher J. McNeil, Alison D. Murray, et al.
Therapeutic Advances in Drug Safety (2020) Vol. 11
Open Access | Times Cited: 320
The silent epidemic of chronic pain in older adults
Anthony F. Domenichiello, Christopher E. Ramsden
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 284-290
Open Access | Times Cited: 297
High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems
Juliana Schneider, Engi Algharably, Andrea Budnick, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 53
Quality of life in patients with fibromyalgia: Contributions of disease symptoms, lifestyle and multi-medication
Fátima Fernández‐Feijoo, Noelia Samartin-Veiga, M. T. Carrillo‐de‐la‐Peña
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 24
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Rachel Nolan, Katelyn Reeb, Yongzhang Rong, et al.
Brain Behavior & Immunity - Health (2019) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 39
Association between polypharmacy and depression: a systematic review and meta‐analysis
Sirinoot Palapinyo, Janthima Methaneethorn, Nattawut Leelakanok
Journal of Pharmacy Practice and Research (2021) Vol. 51, Iss. 4, pp. 280-299
Closed Access | Times Cited: 30
Determinants and consequences of polypharmacy in patients with a depressive disorder in later life
Carlijn Wiersema, Richard C. Oude Voshaar, Rob H. S. van den Brink, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 1, pp. 85-97
Open Access | Times Cited: 20
Polypharmacy and Potentially Inappropriate Medication in Iranian People With Metabolic Syndrome: Epidemiological Aspects and Related Factors, a Multi‐Level Cross‐Sectional National Study
Mojdeh Daneshmand, Hamidreza Jamshidi, Mohammad‐Reza Malekpour, et al.
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
The Relation Between Polypharmacy, Potentially Inappropriate Medications, Organ Function, and Quality of Life in Elderly Patients with Type 2 Diabetes
Hozan Jaza Hama Salh, Tavga Ahmed Aziz, Taha Mahwi, et al.
Hospital Pharmacy (2025)
Closed Access
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
Stephanie Matt, Peter J. Gaskill
Brain Research (2019) Vol. 1723, pp. 146398-146398
Open Access | Times Cited: 27
Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases
Bovornpat Suriyapakorn, Pun Chairat, Suwanan Boonyoprakarn, et al.
PLoS ONE (2019) Vol. 14, Iss. 11, pp. e0225239-e0225239
Open Access | Times Cited: 27
Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Incidence of Depression Among Older Cancer Survivors With Osteoarthritis: A Machine Learning Analysis
Nazneen Fatima Shaikh, Chan Shen, Traci LeMasters, et al.
Cancer Informatics (2023) Vol. 22
Open Access | Times Cited: 7
Associations between polypharmacy and physical performance measures in older adults
Serdar Özkök, Çağlar Özer Aydın, Duygu Erbaş Saçar, et al.
Archives of Gerontology and Geriatrics (2021) Vol. 98, pp. 104553-104553
Closed Access | Times Cited: 16
Examining determinants of control of metabolic syndrome among older adults with NCDs receiving service at NCD Plus clinics: multilevel analysis
Nongnuch Suapumee, Acharaporn Seeherunwong, Napaporn Wanitkun, et al.
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them—A multicenter descriptive study according to medication reviews in Hungarian community pharmacies
András Szilvay, Orsolya Somogyi, Annamária Dobszay, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253645-e0253645
Open Access | Times Cited: 9
Triad of impairment in older people with diabetes-reciprocal relations and clinical implications
Ahmed H. Abdelhafiz, P.C. Davies, Alan J. Sinclair
Diabetes Research and Clinical Practice (2020) Vol. 161, pp. 108065-108065
Closed Access | Times Cited: 9
Editorial: Chronic Pain and Health Disparities in Older Adults With Complex Needs
Maile Karris, Margaret Danilovich
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 6
Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy
Stephanie Matt
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100353-100353
Open Access | Times Cited: 7
Comparison of the prevalence and nature of potentially inappropriate medication use in geriatric outpatients between tertiary and community healthcare settings: a multicenter cross-sectional study
Yan Zeng, Yongpei Yu, Qingyang Liu, et al.
International Journal of Clinical Pharmacy (2022) Vol. 44, Iss. 3, pp. 619-629
Closed Access | Times Cited: 5
A multicentric cross-sectional study to characterize the scale and impact of polypharmacy in rural Indian communities, conducted as part of health workers training
Sangeetha Balaji, Monsurul Hoq, Jachin Velavan, et al.
Journal of Family Medicine and Primary Care (2019) Vol. 8, Iss. 7, pp. 2234-2234
Open Access | Times Cited: 4
Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients
Emin Pala, Süleyman Ersoy, Velittin Selçuk Engin, et al.
Therapies (2021) Vol. 77, Iss. 3, pp. 361-369
Closed Access | Times Cited: 4
Exploring Polypharmacy and Drug Interactions in Geriatric Patients: A Cross-Sectional Study from India
Umaima Farheen Khaiser, Rokeya Sultana, Ranajit Das, et al.
Research Square (Research Square) (2024)
Closed Access
Comparing Potential Drug–Drug Interactions in Companion Animal Medications Using Two Electronic Databases
Tussapon Boonyarattanasoonthorn, Phisit Khemawoot, Anusak Kijtawornrat
Veterinary Sciences (2021) Vol. 8, Iss. 4, pp. 60-60
Open Access | Times Cited: 2
Epidemiology of Polypharmacy, Drug-drug Interaction, and Potentially Inappropriate Medication Among Metabolic Syndrome Patients in Iran: A National, Cross-sectional, Multi-level Study
Mojdeh Daneshmand, Hamidreza Jamshidi, Mohammad‐Reza Malekpour, et al.
Research Square (Research Square) (2023)
Open Access
Statistical concerns about the study: “Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study”
Kübra Aydın, Meryem Merve Ören, Tuğba Aydın
Clinical Interventions in Aging (2018) Vol. Volume 13, pp. 2539-2542
Open Access
Page 1 - Next Page

Scroll to top